Highlights Hunan Jiudian Pharmaceutical Co., Ltd.

Equities

300705

CNE1000034Z6

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 27/05/2024 am IST			5-day change	1st Jan Change
25.56 ^CNY	+0.71%		-1.67%	+7.69%

24/04	Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
26/01	Hunan Jiudian Pharmaceutical Co., Ltd. Elects Yang Yang and Fan Pengyun as Non-Independent Director	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hunan Jiudian Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023	25/04	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23/23/23	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	15/23/15	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Approves 2022 Final Profit Distribution, Payable on May 15, 2023	10/23/10	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Proposes Cash Dividend for the Year of 2022	18/23/18	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14	CI
Hunan Jiudian Pharma Wins Nod to Trial Anti-Inflammatory Patch	05/23/05	MT
Jiudian Pharma Sees FY22 Profit to Rise Up to 33.7%	16/23/16	MT
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/22/30	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 27 May 2022	21/22/21	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021	19/22/19	CI
Nan Jiudian Pharmaceutical Announces Profit Distribution Plan for 2021	28/22/28	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	26/22/26	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	25/21/25	CI
Hunan Jiudian Pharmaceutical Co., Ltd. entered into an agreement to acquire Hunan Huiyang Information Technology Co., Ltd. from Duan Lixin and Duan Linong for CNY 8.56 million.	10/21/10	CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	09/21/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hunan Jiudian Pharmaceutical Co., Ltd.

Equities

300705

CNE1000034Z6

Highlights

Filters